ID   WPE-int
AC   CVCL_K282
DR   BTO; BTO:0006000
DR   ATCC; CRL-2888
DR   BioSample; SAMN03471697
DR   Wikidata; Q54994370
RX   PubMed=16351690;
CC   Population: Caucasian.
CC   Doubling time: ~52 hours (ATCC=CRL-2888).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Misspelling: WPE1-7-1; BioSample=SAMN03471697.
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
ST   Source(s): ATCC
ST   Amelogenin: X
ST   CSF1PO: 13,14
ST   D13S317: 14
ST   D16S539: 9,11
ST   D5S818: 12,15
ST   D7S820: 10,11
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3791 ! RWPE-1
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 15
//
RX   PubMed=16351690; DOI=10.1111/j.1432-0436.2005.00047.x;
RA   Tokar E.J., Ancrile B.B., Cunha G.R., Webber M.M.;
RT   "Stem/progenitor and intermediate cell types and the origin of human
RT   prostate cancer.";
RL   Differentiation 73:463-473(2005).
//